Advertisement

Organisation › Details
Lonza Group AG (SWX: LONN)
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector. Founded in 1897 in the Swiss Alps, today Lonza operates acrossfive continents. With approximately 14,000 full-time employees, we are built from high-performing teams and of individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 4.5 billion in 2020 with a CORE EBITDA of CHF 1.4 billion. Find out more at www.lonza.com *
![]() |
Start | 1999-11-01 splitoff |
![]() |
Industry | contract manufacturing (biologicals) |
Street | 38 Münchensteiner Str. | |
City | 4002 Basel BS | |
Tel | +41-61-316-8111 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | H: 10,001 to 50,00 (2023-12-31) |
Currency | CHF | |
Annual sales | 6,717,000,000 (sales, consolidated (2023) 2023-12-31) | |
Profit | 655,000,000 (2023-12-31) | |
Cash | 1,468,000,000 (2023-12-31) | |
* Document for »About Section«: Lonza Group AG. (5/6/21). "Press Release: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)". Basel. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Lonza (Group)
- [1] Lonza Group AG. (1/19/21). "Press Release: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms". Basel & London....
- [2] Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top